We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-106.00 | -0.87% | 12,050.00 | 12,036.00 | 12,038.00 | 12,178.00 | 12,010.00 | 12,092.00 | 1,635,146 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.34 | 186.61B |
Date | Subject | Author | Discuss |
---|---|---|---|
27/7/2017 12:21 | The Board has recommended an unchanged first interim dividend of $0.90 (68.9 pence, 7.40 SEK) per Ordinary Share. | analyst | |
27/7/2017 12:19 | How much is divi pls Monty? | action | |
27/7/2017 12:14 | Can't see how this dividend can be maintained, will it be cut in the future? | montyhedge | |
27/7/2017 11:46 | American can briefly touch 40 level on opening. Seen it b4 with this share | action | |
27/7/2017 11:43 | London has had its say.Now,it's up to Wall Street.For now the ADRs are trading at near £43-50 but given the opening is three hours off,the current pre opening price isn't a good guide. | steeplejack | |
27/7/2017 11:42 | stewart, when the rally comes I suspect it will be sold into. No hurry to buy this week. | grahamite2 | |
27/7/2017 11:38 | Action, Tempted, plus Int Divi | utyinv | |
27/7/2017 11:29 | Anyone buying here at this level? | action | |
27/7/2017 10:55 | GARYCOOK I noted your comment on the Lloyds thread. Good to see that you have a similar portfolio policy to me. Some of these investors who write books should actually remember we aren't the same as them and are neither in The City or Wall Street. If they got to know their audience their advice would be much different. | minerve | |
27/7/2017 10:50 | Wouldn't you just know it, a drug with the name of Mystic wipes out a sixth of the share value today, obviously I wasn't paying enough attention to the runes or the crystal ball. Meanwhile, a bit surprised that it hasn't rallied yet. Certainly not going to be averaging down on this one, but would be tempted if I didn't have a stake at all at today's price. Also I would be surprised if there were any sellers left. | stewart64 | |
27/7/2017 10:48 | Sooner be in GSK ! | garycook | |
27/7/2017 10:46 | This is oversold IMO. Just looking at TPs, consensus affects on earnings and past share price history I would say a stabilising share price should sit around 4675. | minerve | |
27/7/2017 10:44 | from £55 TO £43 in 12 months. buy and hold is dead. you can lose money in this game very quickly. | careful | |
27/7/2017 10:37 | Was it Goldmans with a sell and £39 target or Jeffries? | steeplejack | |
27/7/2017 10:27 | Goldmans?.......Well | steeplejack | |
27/7/2017 10:20 | Goldman Sachs have called AZN correct with a 3900p TP Issued on 18/07 | garycook | |
27/7/2017 10:10 | Well,I guess the analysts have run their adjustments of new discounted cash flow calculations on Mystic accounting for this giant setback/failure.The share price has retreated back to where it was end Feb.A correction of 15% on the day,is fairly unforgiving but understandable.I'm not selling but I'm unprepared to buy into a dead cat bounce or the wishful thinking of a bid.For now,there's consolation in the dividend. | steeplejack | |
27/7/2017 10:02 | scgl awesome news | falia | |
27/7/2017 09:24 | Sometimes selecting profit making Small Caps works out better AZN today looks like an AIM stock | buywell3 | |
27/7/2017 09:23 | Woodford won't just dump them ! | oakville | |
27/7/2017 09:18 | I bet he sells he's holding. | montyhedge | |
27/7/2017 08:59 | woodford had a shedload of these. we all suffer. bought some this morning. | careful | |
27/7/2017 08:43 | $17b wiped off today wow.... | bigboots | |
27/7/2017 08:20 | CEO said he's not leaving, that a shame. | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions